- Home
- PVBC vs SLDB Comparison
PVBC vs SLDB Comparison
Compare PVBC & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- SLDB
- Stock Information
- Founded
- PVBC 1913
- SLDB 2013
- Country
- PVBC United States
- SLDB United States
- Employees
- PVBC N/A
- SLDB N/A
- Industry
- PVBC Major Banks
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PVBC Finance
- SLDB Health Care
- Exchange
- PVBC Nasdaq
- SLDB Nasdaq
- Market Cap
- PVBC 202.6M
- SLDB 234.8M
- IPO Year
- PVBC 2015
- SLDB 2018
- Fundamental
- Price
- PVBC $12.83
- SLDB $5.28
- Analyst Decision
- PVBC Hold
- SLDB Strong Buy
- Analyst Count
- PVBC 1
- SLDB 10
- Target Price
- PVBC $12.50
- SLDB $15.10
- AVG Volume (30 Days)
- PVBC 251.0K
- SLDB 1.7M
- Earning Date
- PVBC 07-28-2025
- SLDB 08-12-2025
- Dividend Yield
- PVBC N/A
- SLDB N/A
- EPS Growth
- PVBC N/A
- SLDB N/A
- EPS
- PVBC 0.26
- SLDB N/A
- Revenue
- PVBC $50,244,000.00
- SLDB N/A
- Revenue This Year
- PVBC $9.73
- SLDB N/A
- Revenue Next Year
- PVBC $4.87
- SLDB N/A
- P/E Ratio
- PVBC $49.31
- SLDB N/A
- Revenue Growth
- PVBC N/A
- SLDB N/A
- 52 Week Low
- PVBC $9.67
- SLDB $2.41
- 52 Week High
- PVBC $12.96
- SLDB $10.37
- Technical
- Relative Strength Index (RSI)
- PVBC 78.85
- SLDB 65.14
- Support Level
- PVBC $12.60
- SLDB $4.76
- Resistance Level
- PVBC $12.83
- SLDB $5.70
- Average True Range (ATR)
- PVBC 0.17
- SLDB 0.38
- MACD
- PVBC 0.03
- SLDB 0.02
- Stochastic Oscillator
- PVBC 91.15
- SLDB 78.63
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.